Urinary System Disease

Risk factors of poor renal prognosis in children with Henoch-Schönlein purpura nephritis

  • Meiqiu WANG ,
  • Xu HE ,
  • Ren WANG ,
  • Lili JIA ,
  • Chunlin GAO ,
  • Zhengkun XIA
Expand
  • 1. Department of Pediatrics, Nanjing Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210002, Jiangsu, China
    2. Department of Pediatrics, Jinling Hospital, Nanjing 210002, Jiangsu, China

Received date: 2022-11-22

  Online published: 2023-12-04

Abstract

Objective To explore independent risk factors for poor renal outcome defined as an estimated glomerular filtration rate (eGFR)<90 mL/(min·1.73m2) in children with Henoch-Schönlein purpura nephritis (HSPN). Methods The clinical data of children diagnosed with HSPN after completing renal biopsy from January 2000 to December 2019 were retrospectively analyzed, and the independent risk factors leading to poor renal prognosis were analyzed by multivariate logistic regression. Results A total of 476 children with HSPN were included, of whom 31(6.5%) had poor renal outcomes. There were 278 boys and 198 girls, and the age of onset was 10.7 (8.1-13.2) years. The median follow-up time was 33.8 (20.9-54.2) months. Compared with the good prognosis group, the poor prognosis group had older age of onset, longer time from renal involvement to renal aspiration, higher proportions of high uric acid, high cholesterol, eGFR<90 mL/(min·1.73m2), large albuminuria and high urinary retinol binding protein (RBP), and the differences were statistically significant (P<0.05). There were significant differences in segmental glomerulosclerosis/adhesion, >25% renal tubular atrophy/interstitial fibrosis, and the degree of crescent formation between the good and poor prognosis groups (P<0.05). Multivariate logistic regression analysis showed that segmental glomerulosclerosis/adhesion, >25% renal tubular atrophy/interstitial fibrosis and high urinary RBP were independent risk factors for poor renal prognosis (P<0.05). Conclusions This study found three risk factors for poor renal prognosis in children with HSPN, which are worthy of further clinical exploration and verification.

Cite this article

Meiqiu WANG , Xu HE , Ren WANG , Lili JIA , Chunlin GAO , Zhengkun XIA . Risk factors of poor renal prognosis in children with Henoch-Schönlein purpura nephritis[J]. Journal of Clinical Pediatrics, 2023 , 41(12) : 903 -907 . DOI: 10.12372/jcp.2023.22e1553

References

[1] Carucci NS, La Barbera G, Peruzzi L, et al. Time of onset and risk factors of renal involvement in children with Henoch-Sch?nlein purpura: retrospective study[J]. Children (Basel), 2022, 9(9): 1394.
[2] Trapani S, Micheli A, Grisolia F, et al. Henoch Schonlein purpura in childhood: epidemiological and clinical analysis of 150 cases over a 5-year period and review of literature[J]. Semin Arthritis Rheum, 2005, 35(3): 143-153.
[3] Xu S, Han S, Dai Y, et al. A review of the mechanism of vascular endothelial injury in immunoglobulin A vasculitis[J]. Front Physiol, 2022, 13: 833954.
[4] Shang XP, Wu JG, Cheng Y, et al. Epidemiology and clinical characteristics of Henoch-Sch?nlein purpura associated with Mycoplasma pneumoniae infection in 131 children in Hubei Province, China[J]. Mediterr J Hematol Infect Dis, 2021, 13(1): e2021037.
[5] Zhong ZX, Tan JX, Tang Y, et al. Crescent lesions are not a predictive factor in adult-onset Henoch-Sch?nlein purpura nephritis[J]. Clin Exp Med, 2019, 19(4): 449-456.
[6] Kang Z, Xun M, Li Z, et al. Association of the clini-copathological characteristics and proteinuria remission of pediatric IgAV with nephrotic-range proteinuria: a retrospective cohort study[J]. Front Pediatr, 2022, 10: 959212.
[7] 中华医学会儿科学分会肾脏学组. 紫癜性肾炎诊治循证指南(2016)[J]. 中华儿科杂志, 2017, 55(9): 647-651.
[8] Noone DG, Marks SD. Hyperuricemia is associated with hypertension, obesity, and albuminuria in children with chronic kidney disease[J]. J Pediatr, 2013, 162(1): 128-132.
[9] Jan?i? SG, Mo?nik M, Mar?un Varda N. Glomerular filtration rate assessment in children[J]. Children (Basel), 2022, 9(12): 1995.
[10] Giavarina D, Husain-Syed F, Ronco C. Clinical implications of the new equation to estimate glomerular filtration rate[J]. Nephron, 2021, 145(5): 508-512.
[11] Xu K, Zhang L, Ding J, et al. Value of the Oxford classification of IgA nephropathy in children with Henoch-Sch?nlein purpura nephritis[J]. J Nephrol, 2018, 31(2): 279-286.
[12] Haas M, Verhave JC, Liu ZH, et al. A multicenter study of the predictive value of crescents in IgA nephropathy[J]. J Am Soc Nephrol, 2017, 28(2): 691-701.
[13] Pohl M. Henoch-Sch?nlein purpura nephritis[J]. Pediatr Nephrol, 2015, 30(2): 245-252.
[14] Song Y, Huang X, Yu G, et al. Pathogenesis of IgA vasculitis: an up-to-date review[J]. Front Immunol, 2021, 12: 771619.
[15] Yun D, Kim DK, Oh KH, et al. MEST-C pathological score and long-term outcomes of child and adult patients with Henoch-Sch?nlein purpura nephritis[J]. BMC Nephrol, 2020, 21(1): 33.
[16] Jimenez A, Chen A, Lin JJ, et al. Does MEST-C score predict outcomes in pediatric Henoch-Sch?nlein purpura nephritis?[J]. Pediatr Nephrol, 2019, 34(12): 2583-2589.
[17] ?ak?c? EK, Gür G, Yaz?l?ta? F, et al. A retrospective analysis of children with Henoch-Schonlein purpura and re-evaluation of renal pathologies using Oxford classification[J]. Clin Exp Nephrol, 2019, 23(7): 939-947.
[18] Kim CH, Lim BJ, Bae YS, et al. Using the Oxford classification of IgA nephropathy to predict long-term outcomes of Henoch-Sch?nlein purpura nephritis in adults[J]. Mod Pathol, 2014, 27(7): 972-982.
[19] Inagaki K, Kaihan AB, Hachiya A, et al. Clinical impact of endocapillary proliferation according to the Oxford classification among adults with Henoch-Sch?nlein purpura nephritis: a multicenter retrospective cohort study[J]. BMC Nephrol, 2018, 19(1): 208.
[20] Li X, Tang M, Yao X, et al. A clinicopathological comparison between IgA nephropathy and Henoch-Sch?nlein purpura nephritis in children: use of the Oxford classification[J]. Clin Exp Nephrol, 2019, 23(12): 1382-1390.
[21] Huang X, Ma L, Ren P, et al. Updated Oxford classification and the international study of kidney disease in children classification: application in predicting outcome of Henoch-Sch?nlein purpura nephritis[J]. Diagn Pathol, 2019, 14(1): 40.
[22] Delbet JD, Geslain G, Auger M, et al. Histological prognostic factors in children with Henoch-Sch?nlein purpura nephritis[J]. Pediatr Nephrol, 2020, 35(2): 313-320.
[23] Hastings MC, Rizk DV, Kiryluk K, et al. IgA vasculitis with nephritis: update of pathogenesis with clinical implications[J]. Pediatr Nephrol, 2022, 37(4): 719-733.
[24] Hahn D, Hodson EM, Craig JC. Interventions for preventing and treating kidney disease in IgA vasculitis[J]. Cochrane Database Syst Rev, 2023, 2(2): Cd005128.
[25] Lai L, Liu S, Azrad M, et al. IgA vasculitis with nephritis in adults: histological and clinical assessment[J]. J Clin Med, 2021, 10(21): 4851.
[26] Edstr?m Halling S, S?derberg MP, Berg UB. Predictors of outcome in Henoch-Sch?nlein nephritis[J]. Pediatr Nephrol, 2010, 25(6): 1101-1108.
[27] Sobotka R, ?apoun O, Kalousová M, et al. Prognostic importance of vitamins A, E and retinol-binding protein 4 in renal cell carcinoma patients[J]. Anticancer Res, 2017, 37(7): 3801-3806.
[28] Shi D, Chan H, Yang X, et al. Risk factors associated with IgA vasculitis with nephritis (Henoch-Sch?nlein purpura nephritis) progressing to unfavorable outcomes: a meta-analysis[J]. PLoS One, 2019, 14(10): e0223218.
Outlines

/